Microbial Signatures of Obesity-Aggravated Psoriasis: Insights from an Imiquimod-Based Mouse Model
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167697 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Carolina Constantin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, "Victor Babes" National Institute of Pathology, 050096 Bucharest, Romania. Hauptthemen laut MEDLINE: Psoriasis, Obesity, Imiquimod, Gastrointestinal Microbiome. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii, Ministry of Research and Innovation in Romania through Core Program.
Abstract (Originalsprache)
As obesity and Western diet consumption are key factors contributing to gut dysbiosis, we investigated the relationship between intestinal microbiota, obesity, and psoriasis in an imiquimod-based model. C57BL/6 mice were used as follows: psoriasis-induced groups fed continuously with a standard or Western diet, psoriasis-induced group fed with a Western diet and then returned to a standard diet, and controls. For each group, clinicopathological, immune, and metabolic parameters were integrated with microbiome data. The imiquimod-based models displayed human psoriasis features and significant changes in immune parameters. Hence, psoriatic mice on prolonged high-fat intake presented decreased microbial richness and evenness and a gut microbiome composition resembling that of obese mice. Ruminococcus, Clostridium, Desulfovibrio, and Enterorhabdus were the most abundant genera in the obesity-enhanced psoriasis group. Raoultella abundance was linked with psoriasis. Yet, the same pathobionts over-represented in the obese psoriatic mice displayed positive correlations with metabolic stress indicators and proinflammatory factors, indicating potential biomarkers of disease severity. Conversely, Lactobacillus taiwanensis, Alistipes putredinis, and Eubacterium hadrum might be potential taxa for attenuating the metabolic burden in obesity-enhanced psoriasis. Here, we depict the microbial signatures associated with inflammation and metabolic stress in an obesity-aggravated psoriasis mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Department, "Victor Babes" National Institute of Pathology, 050096 Bucharest, Romania.
- Colentina Clinical Hospital, 020125 Bucharest, Romania.
- European Virus Bioinformatics Center, University of Jena, 07743 Jena, Germany.
- Animal Husbandry, "Victor Babes" National Institute of Pathology, 050096 Bucharest, Romania.
- Faculty of Biology, University of Bucharest, 050095 Bucharest, Romania.
ORCID-Profile: Carolina Constantin, Elena-Georgiana Dobre, Adriana Narcisa Munteanu, Mihaela Surcel, Gheorghita Isvoranu, Monica Neagu
Förderung
- Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii
- Ministry of Research and Innovation in Romania through Core Program
Zitieren
APA
Constantin, C., Dobre, E. G., Istvan, P., Munteanu, A. N., Surcel, M., Isvoranu, G., & Neagu, M. (2025). Microbial Signatures of Obesity-Aggravated Psoriasis: Insights from an Imiquimod-Based Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167697
Vancouver
Constantin C, Dobre EG, Istvan P, Munteanu AN, Surcel M, Isvoranu G, et al. Microbial Signatures of Obesity-Aggravated Psoriasis: Insights from an Imiquimod-Based Mouse Model. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167697
BibTeX
@article{Constantin2025,
author = {Constantin, Carolina and Dobre, Elena-Georgiana and Istvan, Paula and Munteanu, Adriana Narcisa and Surcel, Mihaela and Isvoranu, Gheorghita and Neagu, Monica},
title = {Microbial Signatures of Obesity-Aggravated Psoriasis: Insights from an Imiquimod-Based Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167697}
}
EUVIMED